Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Tranzyme Seeks Strategic Alternatives | Contract Pharma

What are you searching for?

Sign in
Breaking News

Tranzyme Seeks Strategic Alternatives

To evaluate merger, sale, or other transaction

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Tranzyme, Inc. has decided to explore and evaluate strategic alternatives, including the possibility of a merger, sale, or other transaction to maximize value for stockholders. The company has not made a decision to pursue any specific transaction and has not set a timetable for the strategic review process. Tranzyme has retained Stifel as its financial advisor and Skadden, Arps, Slate, Meagher & Flom LLP as its legal counsel to assist with the strategic review process.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters